Observational Study
Copyright ©The Author(s) 2016.
World J Transplant. Dec 24, 2016; 6(4): 729-735
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.729
Figure 1
Figure 1 Patients’ Epstein-Barr virus serostatus pre-heart transplant, post-transplant Epstein-Barr virus viral load as determined by whole blood polymerase chain reaction and incidence of post-transplant lymphoproliferative disorder for the entire cohort. EBV: Epstein-Barr virus; PTLD: Post-transplant lymphoproliferative disorder; PCR: Polymerase chain reaction.